APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026196 pages

Choose your research edition.

Industry ResearchIntravenous Drug Delivery Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Drug Delivery Devices Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Drug Delivery Devices Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Drug Delivery Devices Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Drug Delivery Devices include Johnson & Johnson, Novartis, Pfizer, Teva Pharmaceuticals, Schott, Novo Nordisk, Insulet Corporation, Gerresheimer and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Drug Delivery Devices Segment by Company

Johnson & Johnson

Novartis

Pfizer

Teva Pharmaceuticals

Schott

Novo Nordisk

Insulet Corporation

Gerresheimer

Eli Lilly and Company

Cardinal Health

Becton Dickinson and Company

Baxter International

B. Braun Melsungen AG

Intravenous Drug Delivery Devices Segment by Type

Auto-injectors (Syringe and Cartridge Based)

Pen Injectors

Others

Intravenous Drug Delivery Devices Segment by Application

Home Care

Nursing Homes

Hospitals

Others

Intravenous Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Drug Delivery Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous Drug Delivery Devices Industry Trends Table 2. Intravenous Drug Delivery Devices Industry Drivers Table 3. Intravenous Drug Delivery Devices Industry Opportunities and Challenges Table 4. Intravenous Drug Delivery Devices Industry Restraints Table 5. Global Intravenous Drug Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous Drug Delivery Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intravenous Drug Delivery Devices Sales Market Share by Manufacturers Table 9. Global Intravenous Drug Delivery Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Intravenous Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous Drug Delivery Devices Manufacturers, Product Type & Application Table 13. Global Intravenous Drug Delivery Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Auto-injectors (Syringe and Cartridge Based) Table 17. Major Manufacturers of Pen Injectors Table 18. Major Manufacturers of Others Table 19. Global Intravenous Drug Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Intravenous Drug Delivery Devices Sales by Type (2021-2026) & (k units) Table 21. Global Intravenous Drug Delivery Devices Sales by Type (2027-2032) & (k units) Table 22. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 23. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 24. Global Intravenous Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Intravenous Drug Delivery Devices Revenue by Type (2021-2026) & (k units) Table 26. Global Intravenous Drug Delivery Devices Revenue by Type (2027-2032) & (k units) Table 27. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 28. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Home Care Table 30. Major Manufacturers of Nursing Homes Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Others Table 33. Global Intravenous Drug Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Intravenous Drug Delivery Devices Sales by Application (2021-2026) & (k units) Table 35. Global Intravenous Drug Delivery Devices Sales by Application (2027-2032) & (k units) Table 36. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 37. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 38. Global Intravenous Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Intravenous Drug Delivery Devices Revenue by Application (2021-2026) & (k units) Table 40. Global Intravenous Drug Delivery Devices Revenue by Application (2027-2032) & (k units) Table 41. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 42. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 43. Global Intravenous Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Intravenous Drug Delivery Devices Sales by Region (2021-2026) & (k units) Table 45. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 46. Global Intravenous Drug Delivery Devices Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Intravenous Drug Delivery Devices Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Intravenous Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 50. North America Intravenous Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 51. Europe Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Intravenous Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 53. Europe Intravenous Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Intravenous Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Intravenous Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 60. Global Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Intravenous Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Intravenous Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 64. Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novartis Intravenous Drug Delivery Devices Product Portfolio Table 74. Novartis Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Intravenous Drug Delivery Devices Product Portfolio Table 79. Pfizer Recent Development Table 80. Teva Pharmaceuticals Company Information Table 81. Teva Pharmaceuticals Business Overview Table 82. Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio Table 84. Teva Pharmaceuticals Recent Development Table 85. Schott Company Information Table 86. Schott Business Overview Table 87. Schott Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Schott Intravenous Drug Delivery Devices Product Portfolio Table 89. Schott Recent Development Table 90. Novo Nordisk Company Information Table 91. Novo Nordisk Business Overview Table 92. Novo Nordisk Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio Table 94. Novo Nordisk Recent Development Table 95. Insulet Corporation Company Information Table 96. Insulet Corporation Business Overview Table 97. Insulet Corporation Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio Table 99. Insulet Corporation Recent Development Table 100. Gerresheimer Company Information Table 101. Gerresheimer Business Overview Table 102. Gerresheimer Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Gerresheimer Intravenous Drug Delivery Devices Product Portfolio Table 104. Gerresheimer Recent Development Table 105. Eli Lilly and Company Company Information Table 106. Eli Lilly and Company Business Overview Table 107. Eli Lilly and Company Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio Table 109. Eli Lilly and Company Recent Development Table 110. Cardinal Health Company Information Table 111. Cardinal Health Business Overview Table 112. Cardinal Health Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Cardinal Health Intravenous Drug Delivery Devices Product Portfolio Table 114. Cardinal Health Recent Development Table 115. Becton Dickinson and Company Company Information Table 116. Becton Dickinson and Company Business Overview Table 117. Becton Dickinson and Company Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio Table 119. Becton Dickinson and Company Recent Development Table 120. Baxter International Company Information Table 121. Baxter International Business Overview Table 122. Baxter International Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Baxter International Intravenous Drug Delivery Devices Product Portfolio Table 124. Baxter International Recent Development Table 125. B. Braun Melsungen AG Company Information Table 126. B. Braun Melsungen AG Business Overview Table 127. B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio Table 129. B. Braun Melsungen AG Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Intravenous Drug Delivery Devices Distributors List Table 133. Intravenous Drug Delivery Devices Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Intravenous Drug Delivery Devices Product Image Figure 2. Global Intravenous Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Drug Delivery Devices Sales (2021-2032) & (k units) Figure 5. Global Intravenous Drug Delivery Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Auto-injectors (Syringe and Cartridge Based) Image Figure 9. Pen Injectors Image Figure 10. Others Image Figure 11. Global Intravenous Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Intravenous Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 14. Global Intravenous Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Intravenous Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 17. Home Care Image Figure 18. Nursing Homes Image Figure 19. Hospitals Image Figure 20. Others Image Figure 21. Global Intravenous Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Intravenous Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 24. Global Intravenous Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Intravenous Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 27. North America Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Intravenous Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 29. U.S. Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Intravenous Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 34. Germany Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Intravenous Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 41. China Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Intravenous Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 49. Brazil Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Intravenous Drug Delivery Devices Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Intravenous Drug Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Intravenous Drug Delivery Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Intravenous Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 60. North America Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Intravenous Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 62. Europe Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Intravenous Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Intravenous Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Intravenous Drug Delivery Devices Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Intravenous Drug Delivery Devices Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Auto-injectors (Syringe and Cartridge Based)
  • Pen Injectors
  • Others
Applications
  • Home Care
  • Nursing Homes
  • Hospitals
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Teva Pharmaceuticals
  • Schott
  • Novo Nordisk
  • Insulet Corporation
  • Gerresheimer
  • Eli Lilly and Company
  • Cardinal Health
  • Becton Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Drug Delivery Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Drug Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous Drug Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous Drug Delivery Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous Drug Delivery Devices Market Dynamics
  1. 2.1 Intravenous Drug Delivery Devices Industry Trends
  2. 2.2 Intravenous Drug Delivery Devices Industry Drivers
  3. 2.3 Intravenous Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Intravenous Drug Delivery Devices Industry Restraints
3 Intravenous Drug Delivery Devices Market by Manufacturers
  1. 3.1 Global Intravenous Drug Delivery Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous Drug Delivery Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Drug Delivery Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous Drug Delivery Devices Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous Drug Delivery Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Drug Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Drug Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Drug Delivery Devices Tier 1, Tier 2, and Tier 3
4 Intravenous Drug Delivery Devices Market by Type
  1. 4.1 Intravenous Drug Delivery Devices Type Introduction
  2. 4.1.1 Auto-injectors (Syringe and Cartridge Based)
  3. 4.1.2 Pen Injectors
  4. 4.1.3 Others
  5. 4.2 Global Intravenous Drug Delivery Devices Sales by Type
  6. 4.2.1 Global Intravenous Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intravenous Drug Delivery Devices Sales by Type (2021-2032)
  8. 4.2.3 Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021-2032)
  9. 4.3 Global Intravenous Drug Delivery Devices Revenue by Type
  10. 4.3.1 Global Intravenous Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intravenous Drug Delivery Devices Revenue by Type (2021-2032)
  12. 4.3.3 Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021-2032)
5 Intravenous Drug Delivery Devices Market by Application
  1. 5.1 Intravenous Drug Delivery Devices Application Introduction
  2. 5.1.1 Home Care
  3. 5.1.2 Nursing Homes
  4. 5.1.3 Hospitals
  5. 5.1.4 Others
  6. 5.2 Global Intravenous Drug Delivery Devices Sales by Application
  7. 5.2.1 Global Intravenous Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intravenous Drug Delivery Devices Sales by Application (2021-2032)
  9. 5.2.3 Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021-2032)
  10. 5.3 Global Intravenous Drug Delivery Devices Revenue by Application
  11. 5.3.1 Global Intravenous Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intravenous Drug Delivery Devices Revenue by Application (2021-2032)
  13. 5.3.3 Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021-2032)
6 Global Intravenous Drug Delivery Devices Sales by Region
  1. 6.1 Global Intravenous Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Drug Delivery Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous Drug Delivery Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous Drug Delivery Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous Drug Delivery Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous Drug Delivery Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous Drug Delivery Devices Revenue by Region
  1. 7.1 Global Intravenous Drug Delivery Devices Revenue by Region
  2. 7.1.1 Global Intravenous Drug Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous Drug Delivery Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous Drug Delivery Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous Drug Delivery Devices Revenue (2021-2032)
  8. 7.2.2 North America Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous Drug Delivery Devices Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous Drug Delivery Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous Drug Delivery Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Intravenous Drug Delivery Devices Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Intravenous Drug Delivery Devices Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Teva Pharmaceuticals
  20. 8.4.1 Teva Pharmaceuticals Company Information
  21. 8.4.2 Teva Pharmaceuticals Business Overview
  22. 8.4.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio
  24. 8.4.5 Teva Pharmaceuticals Recent Developments
  25. 8.5 Schott
  26. 8.5.1 Schott Company Information
  27. 8.5.2 Schott Business Overview
  28. 8.5.3 Schott Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Schott Intravenous Drug Delivery Devices Product Portfolio
  30. 8.5.5 Schott Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Insulet Corporation
  38. 8.7.1 Insulet Corporation Company Information
  39. 8.7.2 Insulet Corporation Business Overview
  40. 8.7.3 Insulet Corporation Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio
  42. 8.7.5 Insulet Corporation Recent Developments
  43. 8.8 Gerresheimer
  44. 8.8.1 Gerresheimer Company Information
  45. 8.8.2 Gerresheimer Business Overview
  46. 8.8.3 Gerresheimer Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gerresheimer Intravenous Drug Delivery Devices Product Portfolio
  48. 8.8.5 Gerresheimer Recent Developments
  49. 8.9 Eli Lilly and Company
  50. 8.9.1 Eli Lilly and Company Company Information
  51. 8.9.2 Eli Lilly and Company Business Overview
  52. 8.9.3 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio
  54. 8.9.5 Eli Lilly and Company Recent Developments
  55. 8.10 Cardinal Health
  56. 8.10.1 Cardinal Health Company Information
  57. 8.10.2 Cardinal Health Business Overview
  58. 8.10.3 Cardinal Health Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cardinal Health Intravenous Drug Delivery Devices Product Portfolio
  60. 8.10.5 Cardinal Health Recent Developments
  61. 8.11 Becton Dickinson and Company
  62. 8.11.1 Becton Dickinson and Company Company Information
  63. 8.11.2 Becton Dickinson and Company Business Overview
  64. 8.11.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio
  66. 8.11.5 Becton Dickinson and Company Recent Developments
  67. 8.12 Baxter International
  68. 8.12.1 Baxter International Company Information
  69. 8.12.2 Baxter International Business Overview
  70. 8.12.3 Baxter International Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Baxter International Intravenous Drug Delivery Devices Product Portfolio
  72. 8.12.5 Baxter International Recent Developments
  73. 8.13 B. Braun Melsungen AG
  74. 8.13.1 B. Braun Melsungen AG Company Information
  75. 8.13.2 B. Braun Melsungen AG Business Overview
  76. 8.13.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio
  78. 8.13.5 B. Braun Melsungen AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Intravenous Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Drug Delivery Devices Production Mode & Process
  6. 9.2 Intravenous Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Drug Delivery Devices Distributors
  9. 9.2.3 Intravenous Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst